| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | ErbB-3 predicts survival in ovarian cancer. | J Clin Oncol | 2006 | 1.64 |
| 2 | Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells. | Cancer Res | 2005 | 1.23 |
| 3 | ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions. | Cancer Res | 2006 | 1.06 |
| 4 | Dephosphorylation of p-ERK1/2 in relation to tumor remission after HER-2 and Raf1 blocking therapy in a conditional mouse tumor model. | Mol Carcinog | 2006 | 0.77 |